STOCK TITAN
  1. Home
  2. News
  3. SYK

Stryker Corporation - SYK STOCK NEWS

Welcome to our dedicated page for Stryker Corporation news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker Corporation stock.

Stryker Corporation, based in Kalamazoo, Michigan, is an American multinational renowned for its groundbreaking medical technologies. The company designs, manufactures, and markets a wide array of medical equipment and devices that play critical roles in healthcare settings around the globe.

Stryker's comprehensive product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices. The company is a dominant force in the medical sector, holding a top-three position in reconstructive orthopedic implants and leading in operating room equipment.

In the most recent financial updates, Stryker reported impressive operating results for the fourth quarter and the full year of 2023. With organic sales growth exceeding 11% and surpassing $20 billion in sales, the company has shown robust performance. Kevin Lobo, Chair and CEO, attributes this success to the dedicated teams driving high growth and strong adjusted earnings.

Stryker's influence extends globally, impacting over 150 million patients annually through its work in MedSurg, Neurotechnology, Orthopaedics, and Spine. Just over a quarter of its total revenue is generated from markets outside the United States, highlighting its international presence and reach.

The company continues to innovate and expand its horizons. For instance, Stryker will disclose its financial results for the first quarter of fiscal year 2024 on April 30, 2024. This forthcoming report is anticipated to provide further insights into the company’s financial health and ongoing projects.

For those interested in staying updated, Stryker's press releases and financial disclosures are readily available on their website. The corporation maintains a strong commitment to improving healthcare outcomes and enhancing patient care through its innovative products and services.

News

First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada

Rhea-AI Summary
Stryker (SYK) announces successful completion of the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance, a new tool for surgeons to execute pre-operative plans with 3D imaging and operate with more precision and consistency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
-
News

Stryker announces 2023 sales surpassed $20 billion

Rhea-AI Summary
Stryker (SYK) achieved a historic milestone by surpassing $20 billion in annual sales for the first time in December 2023. Kevin Lobo, Chair and CEO, expressed excitement over this achievement, highlighting the positive impact on customers and patients. Stryker will provide further details on its 2023 financial performance during the Q4 and Full Year Earnings Call on January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none
-
News

Stryker to announce financial results for its fourth quarter and full year 2023

Rhea-AI Summary
Stryker (NYSE:SYK) will report financial results for Q4 and full year 2023 on January 30, 2024. The press release will include summary financial information, and a webcast will be hosted to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
earnings
News

Stryker announces intent to acquire SERF SAS, enhancing its global joint replacement leadership

Rhea-AI Summary
Stryker (SYK) has executed a binding offer to acquire SERF SAS, a France-based joint replacement company known for its innovations in hip implants. The acquisition is expected to complement Stryker's global joint replacement portfolio and expand its presence in France and across Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
acquisition
-
News

Stryker announces intention to nominate a new director, Rachel Ruggeri

Rhea-AI Summary
Stryker (NYSE:SYK) plans to nominate Rachel Ruggeri for its Board of Directors at the 2024 Annual Meeting of Shareholders. With over 25 years of global finance leadership experience, Rachel currently serves as the executive vice president and chief financial officer at Starbucks. She is responsible for the global finance function, including developing and executing financial strategies. Rachel has held various finance leadership positions within Starbucks and has a BA from the University of Puget Sound and an MBA from Washington State University.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
management
-
News

Stryker announces Dr. Srikant Datar will retire from Board of Directors

Rhea-AI Summary
Stryker (NYSE:SYK) announced that Dr. Srikant Datar will not stand for re-election at Stryker's 2024 Annual Meeting of Shareholders. Dr. Datar is the Dean of the Harvard Business School and George F. Baker Professor of Business Administration. He has a strong academic and business background, and his contributions have helped Stryker accelerate global growth through focus on organic and M&A innovation. Stryker is a leading medical technology company offering innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine, impacting over 130 million patients annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
management
News

Stryker declares a $0.80 per share quarterly dividend

Rhea-AI Summary
Stryker (NYSE:SYK) has announced a 6.7% increase in its quarterly dividend to $0.80 per share, payable on January 31, 2024, to shareholders of record as of December 29, 2023. Kevin Lobo, Chair and CEO, stated that this increase aligns with the company's capital allocation strategy, reflecting strong growth and solid financial performance. Stryker is a leading medical technology company offering innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine, impacting over 130 million patients annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
dividends
-
News

Stryker reports third quarter 2023 operating results

Rhea-AI Summary
Stryker reported operating results for Q3 2023. Net sales increased by 9.6% to $4.9 billion. Organic net sales increased by 9.2%. Adjusted operating income margin increased by 110 bps to 23.4%. Reported EPS decreased by 15.9% to $1.80, while adjusted EPS increased by 16.0% to $2.46.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
earnings
-
News

Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary
Stryker (NYSE:SYK) will participate in the 6th Annual Evercore ISI HealthCONx Conference on November 29, 2023. The Company's presentation will be held at the Kimpton EPIC Hotel in Miami, Florida at 1:20 p.m. Eastern Time. The presentation will be given by Glenn Boehnlein, Vice President, Chief Financial Officer, and Jason Beach, Vice President, Investor Relations. A webcast and replay of the presentation will be available on Stryker's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
conferences
News

Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year

Rhea-AI Summary
Stryker showcases Q Guidance System with spine and cranial applications at NASS Annual Meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.38%
Tags
none

FAQ

What is the current stock price of Stryker Corporation (SYK)?

The current stock price of Stryker Corporation (SYK) is $364.1 as of January 8, 2025.

What is the market cap of Stryker Corporation (SYK)?

The market cap of Stryker Corporation (SYK) is approximately 135.4B.

What does Stryker Corporation specialize in?

Stryker Corporation specializes in designing, manufacturing, and marketing medical equipment and devices, including orthopedic implants, endoscopy systems, and operating room equipment.

Where is Stryker Corporation headquartered?

Stryker Corporation is headquartered in Kalamazoo, Michigan, USA.

How did Stryker perform financially in 2023?

Stryker reported excellent organic sales growth of over 11% for both the fourth quarter and the full year of 2023, surpassing $20 billion in sales.

What is the scope of Stryker's global impact?

Stryker impacts over 150 million patients annually and generates just over a quarter of its total revenue from outside the United States.

What are some of the products offered by Stryker?

Stryker's products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices.

When will Stryker report its financial results for Q1 2024?

Stryker will report its financial results for the first quarter of fiscal year 2024 on April 30, 2024.

How can I access Stryker's financial reports?

Stryker's financial reports and press releases can be accessed on their website under the Press Releases and Events & Presentations sections.

Who should I contact for investor inquiries at Stryker?

For investor inquiries, contact Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com.

What areas does Stryker focus its innovations on?

Stryker focuses its innovations on MedSurg, Neurotechnology, Orthopaedics, and Spine to improve patient and healthcare outcomes.

How can I stay updated with Stryker's latest developments?

You can stay updated with Stryker's latest developments by following their press releases and financial disclosures available on their website.
Stock SYK logo
Stryker Corporation

NYSE:SYK

SYK Rankings

#93 Ranked by Market Cap
#1859 Ranked by Dividends

SYK Stock Data

135.40B
360.31M
5.38%
80.47%
1.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
PORTAGE